Spring direct naar de hoofdnavigatie of de inhoud

Jennifer Ebner von Eschenbach

Patent attorney

“Investing that little extra time and effort in IP at the right moment makes your technology go further.”
Home / Experts / Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach

  • Chemistry
  • Life Sciences
  • European Patent Attorney
  • Senior Associate

Jennifer Ebner von Eschenbach began her career as a European patent attorney in 1991 when she commenced her training in the Munich office of the international IP law firm of Ladas & Parry, LLP. Jennifer took over the office management from 1996-2008, during which time she was involved with the prosecution of patent applications for many multinational companies and research institutions. This provided her with an insight of IP needs covering a broad technological spectrum.

More information about Jennifer

Since joining V.O. in 2008, Jennifer has focused on developments in the pharmaceutical and chemical sectors, including novel therapies, diagnostic tools, (bio)technological processes for the employment of renewable resources, as well as environmentally-conscious chemical processes/products, again spanning both a broad range of technologies and clients.

Jennifer has a wide practical experience in procuring and defending patents, including the filing and defense of oppositions. Through the provision of opinions on patent validity and infringement, she also has considerable experience in advising on parties’ freedom to operate.

Working experience

  • Patent Attorney, V.O. (2008-present)
  • Patent Attorney, Ladas & Parry, LLP (1991-2008): Manager of office in Munich (1996-2008)
  • Post-Doctoral Research, Inorganic Chemical Institute of the Technical University of Munich (1989-1990)


  • PhD in Chemistry, University of Melbourne (1988)
  • MSc in Chemistry, University of Melbourne (1984, with honours)


  • •Schmidbaur H., Ebner von Eschenbach J., Kumberger O., & Müller G., Cyclic Dinuclear Gold(I) Complexes: The Crystal Structure of Bis-µ-[(diphenylphosphino)(diphenylphosphinoselenoyl)methane]-digold(I) Bis(perchlorate), Chem. Ber., 123, 2261-2265, 1990
  • Bond A. M., Colton R., Ebner J., & Ellis S. R., Differences in Nature and Stability of Cadmium Complexes with Group 15/Group 16 Donor Ligands as Determined by Multinuclear (31P, 77Se, 113Cd) Magnetic Resonance and Electrochemical Techniques, Inorganic Chemistry, 28, 4509-4516, 1989
  • Colton R., Ebner J., & Hoskins B. F., Multinuclear Magnetic Resonance Studies of the Reactions of Bidentate Ligands with Pt(S2P{OEt}2)2. Crystal and Molecular Structure of (apeS)Pt(S2P{OEt}2)2 (ApeS = Ph2AsCH2CH2P(S)Ph2) , Inorganic Chemistry, 27, 1993-1999, 1988
  • Bond A. M., Colton R., & Ebner J., Multinuclear Magnetic Resonance (31P, 77Se, 199Hg) and Electrochemical Studies of Non-labile Mercury(II) Complexes with Group 15/Group 16 Donor Ligands, Inorganic Chemistry, 27, 1697-1702, 1988


  • German
  • English

Also see these experts

Klok, Martin

Martin Klok

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate

Annemiek Tepper

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
More experts


Benelux Firm of the Year Award for V.O.

We did it again! During the annual Managing IP’s EMEA  Awards Dinner of 8 March, the Benelux Firm of the Year Award was presented to V.O.Continue reading

Patents are the most important indicator of a company’s powers of innovation

In 2016, the European Patent Office (EPO) granted a record number of patents. The USA submitted the most applications by far (40,076). Germany is placed second (25,086), while the Netherlands and Belgium occupy seventh (6,889) and twelfth (2,186) place respectively. But what does a patent say about a company’s powers of innovation?Continue reading

Finding a breakthrough against antibiotic resistance

It was less than a year ago when, brimming with enthusiasm, he opted for the uncertainty of a start-up. Chemist Andreas A. Bastian started his business AGILeBiotics on the Zernike campus of the University of Groningen. His aim is to achieve a breakthrough in the fight against antibiotic resistance: ‘We have since developed a technology […]Continue reading


IPBC Europe 2018: Harnessing IP value in European companies

Hotel Okura Amsterdam, Ferdinand Bolstraat, Amsterdam, Netherlands

European companies are under greater pressure than ever before to maximise the value of the intellectual property they own. This is happening at a time when Brexit and the creation of the Unified Patent Court regime promise some of the most far-reaching changes to the continent’s IP system for many years. More about this event

Seminar “Innovation box”: the fiscal significance of patents

Engels Conference & Meeting Center, Stationsplein 45, 3013 AK Rotterdam, Netherlands

The "innovationbox" (innovatiebox) is an important fiscal instrument for stimulating innovative business activities. It leads to a lower corporate tax on innovation profits. Since the rules for using the innovation box have changed considerably since 1 January 2017, a prominent role is reserved for patents. More about this event

Job fair

Familie van Rysselberghedreef 2, Ghent, Belgium

On Tuesday 27 March 2018 Ghent University Association organises the 15th edition of Flander's largest job fair. The Afstudeerbeurs takes place in the ICC Ghent, from 12:00 hrs till 18:00 hrs. The Afstudeerbeurs consists of 5 components taking place at the same time and in the same location: the general job market, the Job Market for Young Researchers, the International Jobs Corner, the education and further studies fair and a complementary (free of charge) programme of workshops, information sessions and CV analysis. More about this event